Shannon A Novosad1, Emily Henkle2, Sean Schafer3, Katrina Hedberg3, Jennifer Ku4, Sarah A R Siegel2, Dongseok Choi2,5, Christopher G Slatore1,6, Kevin L Winthrop2,4. 1. 1 Division of Pulmonary & Critical Care Medicine, Department of Medicine. 2. 2 School of Public Health, and. 3. 3 Public Health Division, Oregon Health Authority, Portland, Oregon. 4. 4 Division of Infectious Diseases, School of Medicine, Oregon Health & Science University, Portland, Oregon. 5. 5 Graduate School of Dentistry, Kyung Hee University, Seoul, Korea; and. 6. 6 Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, Oregon.
Abstract
RATIONALE: The mortality of patients with respiratory tract isolates of nontuberculous mycobacteria (NTM) and their risk factors for death are not well described. OBJECTIVES: To determine age-adjusted mortality rates for patients with respiratory NTM isolates and their causes of death and to examine whether American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) diagnostic criteria identify those at higher risk of death after NTM isolation. METHODS: We linked vital records registries with a previously identified Oregon population-based cohort of patients with NTM respiratory isolation. We excluded patients with Mycobacterium gordonae (n = 33) and those who died (n = 21) at the time of first isolation. We calculated 5-year age-adjusted mortality rates. We used Kaplan-Meier and Cox proportional hazards analysis to examine the association of ATS/IDSA criteria and other risk factors with death. RESULTS: Of 368 subjects with respiratory NTM isolates in 2005-2006, 316 were included in the survival analysis. Most (84%) of their cultures isolated Mycobacterium avium complex. 35.1% died in the 5 years following respiratory isolation. Five-year age-adjusted mortality rates were slightly higher for those meeting (28.7/1,000) versus not meeting (23.4/1,000) ATS/IDSA criteria. In multivariate analysis, older age (adjusted hazard ratio [aHR], 1.06; 95% confidence interval [CI], 1.04-1.07) and lung cancer (aHR, 2.77; 95% CI, 1.51-5.07) were associated with an increased risk of death. A trend was noted between meeting ATS/IDSA criteria and subsequent death (aHR, 1.37; 95% CI, 0.95-1.97). Among cases, male sex, older age, and immunosuppressive therapy use were independent risk factors for death. CONCLUSIONS: In the State of Oregon, patients with NTM respiratory isolates have high mortality, regardless of whether they meet ATS/IDSA criteria for pulmonary NTM disease. Most patients die as a result of causes other than NTM infection.
RATIONALE: The mortality of patients with respiratory tract isolates of nontuberculous mycobacteria (NTM) and their risk factors for death are not well described. OBJECTIVES: To determine age-adjusted mortality rates for patients with respiratory NTM isolates and their causes of death and to examine whether American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) diagnostic criteria identify those at higher risk of death after NTM isolation. METHODS: We linked vital records registries with a previously identified Oregon population-based cohort of patients with NTM respiratory isolation. We excluded patients with Mycobacterium gordonae (n = 33) and those who died (n = 21) at the time of first isolation. We calculated 5-year age-adjusted mortality rates. We used Kaplan-Meier and Cox proportional hazards analysis to examine the association of ATS/IDSA criteria and other risk factors with death. RESULTS: Of 368 subjects with respiratory NTM isolates in 2005-2006, 316 were included in the survival analysis. Most (84%) of their cultures isolated Mycobacterium avium complex. 35.1% died in the 5 years following respiratory isolation. Five-year age-adjusted mortality rates were slightly higher for those meeting (28.7/1,000) versus not meeting (23.4/1,000) ATS/IDSA criteria. In multivariate analysis, older age (adjusted hazard ratio [aHR], 1.06; 95% confidence interval [CI], 1.04-1.07) and lung cancer (aHR, 2.77; 95% CI, 1.51-5.07) were associated with an increased risk of death. A trend was noted between meeting ATS/IDSA criteria and subsequent death (aHR, 1.37; 95% CI, 0.95-1.97). Among cases, male sex, older age, and immunosuppressive therapy use were independent risk factors for death. CONCLUSIONS: In the State of Oregon, patients with NTM respiratory isolates have high mortality, regardless of whether they meet ATS/IDSA criteria for pulmonary NTM disease. Most patients die as a result of causes other than NTM infection.
Authors: D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier Journal: Am J Respir Crit Care Med Date: 2010-06-10 Impact factor: 21.405
Authors: David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop Journal: Am J Respir Crit Care Med Date: 2007-02-15 Impact factor: 21.405
Authors: Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots Journal: Am J Respir Crit Care Med Date: 2012-02-03 Impact factor: 21.405
Authors: Mohammed Al Houqani; Frances Jamieson; Pamela Chedore; Mauli Mehta; Kevin May; Theodore K Marras Journal: Can Respir J Date: 2011 Jan-Feb Impact factor: 2.409
Authors: Y Ito; T Hirai; K Maekawa; K Fujita; S Imai; S Tatsumi; T Handa; H Matsumoto; S Muro; A Niimi; M Mishima Journal: Int J Tuberc Lung Dis Date: 2012-01-05 Impact factor: 2.373
Authors: Emily Henkle; Shannon A Novosad; Sean Shafer; Katrina Hedberg; Sarah A R Siegel; Jennifer Ku; Cara Varley; D Rebecca Prevots; Theodore K Marras; Kevin L Winthrop Journal: Ann Am Thorac Soc Date: 2017-07
Authors: Steven A Cowman; Joseph Jacob; Sayed Obaidee; R Andres Floto; Robert Wilson; Charles S Haworth; Michael R Loebinger Journal: BMC Pulm Med Date: 2018-08-31 Impact factor: 3.317
Authors: Ravleen Virdi; Melissa E Lowe; Grant J Norton; Stephanie N Dawrs; Nabeeh A Hasan; L Elaine Epperson; Cody M Glickman; Edward D Chan; Michael Strong; James L Crooks; Jennifer R Honda Journal: Microorganisms Date: 2021-01-22
Authors: Getahun Abate; Jack T Stapleton; Nadine Rouphael; Buddy Creech; Jason E Stout; Hana M El Sahly; Lisa Jackson; Francisco J Leyva; Kay M Tomashek; Melinda Tibbals; Nora Watson; Aaron Miller; Edward Charbek; Joan Siegner; Marcia Sokol-Anderson; Ravi Nayak; Greta Dahlberg; Pat Winokur; Ghina Alaaeddine; Nour Beydoun; Katherine Sokolow; Naomi Prashad Kown; Shanda Phillips; Arthur W Baker; Nicholas Turner; Emmanuel Walter; Elizabeth Guy; Sharon Frey Journal: Clin Infect Dis Date: 2021-04-08 Impact factor: 20.999